ArticleMicrosystems & nanoengineering2025
A non-invasive, flexible, lightweight, and wearable system for real-time ECG monitoring in freely moving mice.
Article in Microsystems & nanoengineering, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- ID2 attenuates post-MI ventricular arrhythmias by targeting GATA4 suppression to preserve mitochondrial function and NaOpen medicine (Warsaw, Poland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
ECG monitoring in mice is an essential tool for assessing physiological health. However, acquiring high-quality ECG signals from freely moving and conscious mice has remained a significant technical challenge. This study presents a non-invasive wearable real-time ECG monitoring platform for mice, integrating hollow ultra-flexible electrodes with a soft wireless circuit system, enabling high-fidelity real-time ECG monitoring during free activity. Using microfabrication and transfer techniques, we developed ultra-flexible electrodes that are scalable for large-area manufacturing and customizable to specific requirements. These electrodes conform tightly to the surfaces of the mouse's heart, abdomen, and limbs, enabling high-quality ECG signal acquisition. Even under 40% strain, the electrodes maintain stable mechanical and electrical performance. Experimental results demonstrate that the acquired ECG signals exhibit clear and distinguishable QRS waveforms, with amplitudes comparable to those obtained using traditional needle electrodes. In addition, we designed and developed a wearable soft wireless circuit system encapsulated in an "electronic backpack" mounted on the mouse's back. This system features low-power wireless signal transmission, enabling real-time, long-term ECG signal acquisition. To validate system performance, we established a mouse myocardial infarction model and used the platform for ECG signal monitoring and analysis. The results showed typical features such as ST-segment elevation and baseline abnormalities, which are highly consistent with clinical observations. The proposed non-invasive wearable ECG monitoring platform provides an innovative, cost-effective solution for high-efficiency physiological signal acquisition and drug evaluation in mice, offering broad application potential and significant value for further development.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.